The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...

The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a ...

In addition, Infinitus is working to improve the evaluation standards for the immunomodulatory effects of complex ...

Executives at iBio (NASDAQ:IBIO) outlined the scientific and strategic rationale for a myostatin/activin A bispecific ...

RFT Writers are a collective of independent journalists contributing original reporting to RFT. They report on a wide range of topics including music, news, gaming, cannabis, and the creator economy.